Cost-efficacy of diabetes screening called into question. PDF Print
Health Day News: Over an average follow-up of nearly 10 years, the overall death rates in the groups that had diabetes screening were no lower than in the group that had no screening. There also was no significant difference between the groups in the number of deaths specifically from diabetes, cardiovascular illness, cancer or other causes. The study appears Oct. 3 in the journal The Lancet.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.